ALK and thyroid tumor: These rearrangements typically involve NTRK1, NTRK3, or ALK, with various fusion partners (72, 73, 74, 79, 80), and have been shown to induce thyroid tumors in vivo (Fig. 1 and Table 2) (81, 82).